Key points are not available for this paper at this time.
Tumor STAS should be considered as an adverse prognostic indicator for patients with stage I lung ADC, especially for those under limited resection. More intensive medical care for those patients needs to be investigated in further studies.
Huang et al. (Thu,) studied this question.